Menquadfi
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN · Injection, Solution · Intramuscular
No FDA structured label text is available for Menquadfi. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen in 2 products
- Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen in 2 products
- Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen in 2 products
- Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen in 2 products
Menquadfi NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 50090-6180 | Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen 10 ug/.5mL; Neisseria… Injection, Solution | A-S Medication Solutions | BLA |
| 49281-590 | Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen 10 ug/.5mL; Neisseria… Injection, Solution | Sanofi Vaccines US Inc. | BLA |
Frequently asked questions
Who makes Menquadfi?
Menquadfi is listed by 2 labelers in the FDA NDC directory, including A-S Medication Solutions, Sanofi Vaccines US Inc..